AAAAAA

   
Results: 1-8 |
Results: 8
Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox (R) Antimicrobial Potency Study (ZAPS) in the United States
Authors: Jones, RN Ballow, CH Biedenbach, DJ
Citation: Rn. Jones et al., Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox (R) Antimicrobial Potency Study (ZAPS) in the United States, DIAG MICR I, 40(1-2), 2001, pp. 59-66
Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients
Authors: Smith, PF Ballow, CH Booker, BM Forrest, A Schentag, JJ
Citation: Pf. Smith et al., Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients, CLIN THER, 23(8), 2001, pp. 1231-1244
New agents for Gram-positive bacteria
Authors: Bhavnani, SM Ballow, CH
Citation: Sm. Bhavnani et Ch. Ballow, New agents for Gram-positive bacteria, CURR OPIN M, 3(5), 2000, pp. 528-534
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
Authors: Bhavnani, SM Drake, JA Forrest, A Deinhart, JA Jones, RN Biedenbach, DJ Ballow, CH
Citation: Sm. Bhavnani et al., A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia, DIAG MICR I, 36(3), 2000, pp. 145-158
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables
Authors: Tran, JQ Ballow, CH Forrest, A Hyatt, JM Sands, MF Peloquin, CA Schentag, JJ
Citation: Jq. Tran et al., Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables, J ANTIMICRO, 45, 2000, pp. 9-17
Absolute bioavailability and disposition of (-) and (+) 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC) following single intravenous and oral doses of racemic dOTC in humans
Authors: Smith, PF Forrest, A Ballow, CH Martin, DE Proulx, L
Citation: Pf. Smith et al., Absolute bioavailability and disposition of (-) and (+) 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC) following single intravenous and oral doses of racemic dOTC in humans, ANTIM AG CH, 44(6), 2000, pp. 1609-1615
Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males
Authors: Smith, PF Forrest, A Ballow, CH Martin, DE Proulx, L
Citation: Pf. Smith et al., Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males, ANTIM AG CH, 44(10), 2000, pp. 2816-2823
Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy
Authors: Highet, VS Forrest, A Ballow, CH Schentag, JJ
Citation: Vs. Highet et al., Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy, J ANTIMICRO, 43, 1999, pp. 55-63
Risultati: 1-8 |